Education
About Us
Working with TipRanks
Follow Us
EZZ Life Science Holdings Ltd. (AU:EZZ)
:EZZ
RESEARCH TOOLSreports
Total Valuation
EZZ Life Science Holdings Ltd. has a market cap or net worth of AU$70.76M. The enterprise value is ―.
Market CapAU$70.76M
Enterprise Value―
Share Statistics
EZZ Life Science Holdings Ltd. has 47,173,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding47,173,200
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
EZZ Life Science Holdings Ltd.’s return on equity (ROE) is 0.33 and return on invested capital (ROIC) is 31.61%.
Return on Equity (ROE)0.33
Return on Assets (ROA)0.27
Return on Invested Capital (ROIC)31.61%
Return on Capital Employed (ROCE)0.45
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover2.60
Inventory Turnover11.06
Valuation Ratios
The current PE Ratio of EZZ Life Science Holdings Ltd. is 11.38. EZZ Life Science Holdings Ltd.’s PEG ratio is 0.28.
PE Ratio11.38
PS Ratio0.00
PB Ratio2.65
Price to Fair Value3.72
Price to FCF8.96
Price to Operating Cash Flow7.99
PEG Ratio0.28
Income Statement
In the last 12 months, EZZ Life Science Holdings Ltd. had revenue of 66.44M and earned 6.96M in profits. Earnings per share was 0.16.
Revenue66.44M
Gross Profit50.95M
Operating Income9.72M
Pretax Income9.96M
Net Income6.96M
EBITDA10.38M
Earnings Per Share (EPS)0.16
Cash Flow
In the last 12 months, operating cash flow was 7.97M and capital expenditures -568.04K, giving a free cash flow of 7.40M billion.
Operating Cash Flow7.97M
Free Cash Flow7.40M
Free Cash Flow per Share0.16
Dividends & Yields
EZZ Life Science Holdings Ltd. pays an annual dividend of AU$0.019, resulting in a dividend yield of 2.67%
Dividend Per ShareAU$0.019
Dividend Yield2.67%
Payout Ratio9.22%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.13
52-Week Price Change37.61%
50-Day Moving Average1.49
200-Day Moving Average2.40
Relative Strength Index (RSI)47.17
Average Volume (3m)36.78K
Important Dates
EZZ Life Science Holdings Ltd. upcoming earnings date is Aug 27, 2025, TBA Not Confirmed.
Last Earnings DateFeb 25, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend DateMay 16, 2025
Financial Position
EZZ Life Science Holdings Ltd. as a current ratio of 5.96, with Debt / Equity ratio of 1.99%
Current Ratio5.96
Quick Ratio5.63
Debt to Market Cap0.00
Net Debt to EBITDA-1.82
Interest Coverage Ratio392.52
Taxes
In the past 12 months, EZZ Life Science Holdings Ltd. has paid 2.99M in taxes.
Income Tax2.99M
Effective Tax Rate0.30
Enterprise Valuation
EZZ Life Science Holdings Ltd. EV to EBITDA ratio is 5.82, with an EV/FCF ratio of 10.53.
EV to Sales0.91
EV to EBITDA5.82
EV to Free Cash Flow10.53
EV to Operating Cash Flow9.83
Balance Sheet
EZZ Life Science Holdings Ltd. has AU$19.89M in cash and marketable securities with AU$478.59K in debt, giving a net cash position of -AU$19.41M billion.
Cash & Marketable SecuritiesAU$19.89M
Total DebtAU$478.59K
Net Cash-AU$19.41M
Net Cash Per Share-AU$0.41
Tangible Book Value Per ShareAU$0.49
Margins
Gross margin is 77.36%, with operating margin of 14.62%, and net profit margin of 10.48%.
Gross Margin77.36%
Operating Margin14.62%
Pretax Margin14.99%
Net Profit Margin10.48%
EBITDA Margin15.62%
EBIT Margin15.03%
Analyst Forecast
The average price target for EZZ Life Science Holdings Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast71.65%
EPS Growth Forecast152.89%